Showing 1 - 3 results of 3 for search 'M. Shahzad Rauf', query time: 0.02s Refine Results
  1. 1
    Risk of hematological malignancies in the families of patients treated for nodular lymphocyte-predominant Hodgkin lymphoma

    Risk of hematological malignancies in the families of patients treated for nodular lymphocyte-predominant Hodgkin lymphoma by Saad Akhtar, M. Shahzad Rauf, Amani Al-Kofide, Mahmoud A. Elshenawy, Ali Hassan Mushtaq, Irfan Maghfoor

    Published 2021-02-01
    Get full text
    Article
  2. 2
    Survival benefit of surgical resection after first-line triplet chemotherapy and bevacizumab in patients with initially unresectable metastatic colorectal cancer

    Survival benefit of surgical resection after first-line triplet chemotherapy and bevacizumab in patients with initially unresectable metastatic colorectal cancer by Mahmoud A. Elshenawy, Ahmed Badran, Ali Aljubran, Ahmed Alzahrani, M. Shahzad Rauf, Abdelmoneim Eldali, Shouki Bazarbashi

    Published 2020-07-01
    Get full text
    Article
  3. 3
    Nodular lymphocyte-predominant Hodgkin lymphoma characteristics, management of primary and relapsed/refractory disease and outcome analysis: the first comprehensive report from the Middle East

    Nodular lymphocyte-predominant Hodgkin lymphoma characteristics, management of primary and relapsed/refractory disease and outcome analysis: the first comprehensive report from the... by Saad Akhtar, M. Shahzad Rauf, Yasser Khafaga, Amani Al-Kofide, Tusneem Ahmed M. Elhassan, Mahmoud A. Elshenawy, Juzer Nadri, Ali Hassan Mushtaq, Nasir Bakshi, Mohammed Shamayel, Suleiman Al-Sweedan, Sohail Sarwar, Irfan Maghfoor

    Published 2021-04-01
    Get full text
    Article

Search Tools: